A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) With or Without Interferon Gamma in Patients With Refractory Pediatric Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2018
At a glance
- Drugs Lexatumumab (Primary) ; Interferon gamma
- Indications CNS cancer; Ewing's sarcoma; Hodgkin's disease; Liver cancer; Lymphoma; Neuroblastoma; Non-Hodgkin's lymphoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Solid tumours; Wilms' tumour
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated